Evidence map›Paper›PMID 32705253›Full record

ArticleMolecular medicine reports2020

Low expression of miR‑532‑3p contributes to cerebral ischemia/reperfusion oxidative stress injury by directly targeting NOX2.

Li Mao, Mei-Ling Zuo, Ai-Ping Wang, Ying Tian, Li-Chen Dong, Tao-Ming Li, Da-Bin Kuang, Gui-Lin Song, Zhong-Bao Yang

Open access · hybridAbstract read
In one paragraph

Article in Molecular medicine reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. [LncRNA SNHG8 inhibits miR-494-3p expression to alleviate cerebral ischemia-reperfusion injury in mice].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2023
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Li Mao *Office of Good Clinical Practice, The Affiliated Changsha Hospital of Hunan, Normal University, Changsha, Hunan 410006, P.R. China.
Mei-Ling Zuo *Office of Good Clinical Practice, The Affiliated Changsha Hospital of Hunan, Normal University, Changsha, Hunan 410006, P.R. China.
Ai-Ping WangInstitute of Clinical Research, Affiliated Nanhua Hospital, University of South China, Hengyang, Hunan 421001, P.R. China.
Ying TianInstitute of Clinical Research, Affiliated Nanhua Hospital, University of South China, Hengyang, Hunan 421001, P.R. China.
Li-Chen DongOffice of Good Clinical Practice, The Affiliated Changsha Hospital of Hunan, Normal University, Changsha, Hunan 410006, P.R. China.
Tao-Ming LiOffice of Good Clinical Practice, The Affiliated Changsha Hospital of Hunan, Normal University, Changsha, Hunan 410006, P.R. China.
Da-Bin KuangOffice of Good Clinical Practice, The Affiliated Changsha Hospital of Hunan, Normal University, Changsha, Hunan 410006, P.R. China.
Gui-Lin SongOffice of Good Clinical Practice, The Affiliated Changsha Hospital of Hunan, Normal University, Changsha, Hunan 410006, P.R. China.
Zhong-Bao YangOffice of Good Clinical Practice, The Affiliated Changsha Hospital of Hunan, Normal University, Changsha, Hunan 410006, P.R. China.
Hunan Normal University · CNUniversity of South China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

NADPH oxidase 2 (NOX2) is a major subtype of NOX and is responsible for the generation of reactive oxygen species (ROS) in brain tissues. MicroRNAs (miRNAs/miRs) are important epigenetic regulators of NOX2. The present study aimed to identify the role of NOX2 miRNA‑targets in ischemic stroke (IS). A rat cerebral ischemia/reperfusion (CI/R) injury model and a SH‑SY5Y cell hypoxia/reoxygenation (H/R) model were used to simulate IS. Gene expression levels, ROS production and apoptosis in tissue or cells were determined, and bioinformatic analysis was conducted for target prediction of miRNA. In vitro experiments, including function‑gain and luciferase activity assays, were also performed to assess the roles of miRNAs. The results indicated that NOX2 was significantly increased in brain tissues subjected to I/R and in SH‑SY5Y cells subjected to H/R, while the expression of miR‑532‑3p (putative target of NOX2) was significantly decreased in brain tissues and plasma. Overexpression of miR‑532‑3p significantly suppressed NOX2 expression and ROS generation in SH‑SY5Y cells subjected to H/R, as well as reduced the relative luciferase activity of cells transfected with a reporter gene plasmid. Collectively, these data indicated that miR‑532‑3p may be a target of NOX2 and a biomarker for CI/R injury. Thus, the present study may provide a novel target for drug development and IS therapy.

Indexed as

3' Untranslated RegionsAnimalsBiomarkersBrainBrain IschemiaCell LineDisease Models, AnimalDown-RegulationGene Expression ProfilingHumansMaleMicroRNAsNADPH Oxidase 2RatsReactive Oxygen Species3' Untranslated RegionsBiomarkersCYBB protein, humanMicroRNAsMIRN532 microRNA, humanNADPH Oxidase 2Reactive Oxygen Speciescerebral ischemia/reperfusion injurymicrorna-532-3pnadPH oxidase 2oxidative stressreactive oxygen species

Identifiers

PMID32705253
PMCPMC7411405
OpenAlexW3041039413

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.